Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDiarrhoea is one of the more common side effects of Wegovy (semaglutide), reported by a meaningful proportion of people during the early weeks of treatment or after each dose increase. For most, it is loose, brief and self-limiting — not a sign that something has gone seriously wrong. That said, knowing what a normal GI reaction looks like versus a signal that needs urgent attention is genuinely useful, so that's exactly what this page covers. Wegovy is a prescription-only medicine requiring clinical assessment; a prescriber decides whether it is right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common thing people assume when diarrhoea starts shortly after their first Wegovy pen is that something has gone wrong, either with the medicine or with them. In reality, the gastrointestinal system is responding to a drug that deliberately slows gastric emptying and alters gut-hormone signalling. The gut notices. That noticing, for many people, produces looser stools, more frequent trips to the bathroom, or an urgency they weren't expecting.
This pattern is well-documented in the clinical trial data. The NHS medicines page for semaglutide lists diarrhoea among the common side effects, alongside nausea, vomiting and constipation. It doesn't mean your body is rejecting the treatment. For most people, symptoms are mild to moderate and ease within one to two weeks as the gut adjusts to the new dose.
The broader context on Wegovy's side effect profile shows that GI effects are the most reported category across the board, and diarrhoea is no exception. Treating it as a signal to stop immediately (without speaking to your prescriber) means many people abandon a treatment that would have settled down on its own.
That is not the same as tolerating something severe. But the starting point is calibration, not alarm.
Timing is one of the clearest indicators of whether loose stools are treatment-related. Diarrhoea with Wegovy tends to cluster in two predictable windows: the first two to four weeks of starting the medicine at any dose, and the few days following a dose increase. The 0.25mg starting dose can cause it; so can the move to 0.5mg, 1.0mg, 1.7mg and 2.4mg, though sensitivity varies considerably between individuals.
The mechanism is straightforward. Semaglutide slows how quickly the stomach empties, which changes the transit time for food moving through the gut. That change affects the consistency of stools and can trigger an urgency response, particularly early on. As the gut adapts, the effect usually reduces.
Practically, the people who find diarrhoea from Wegovy most disruptive tend to be those who eat high-fat or very rich meals, since fat absorption is already affected. If you want a closer look at how Wegovy can cause diarrhoea and what drives the symptom, that page covers the mechanisms and management options in detail. Staying hydrated matters too, not just for comfort but because repeated loose stools can deplete fluids and electrolytes more quickly than people realise.
Your pen lives in the fridge, keep a glass of water nearby as a simple habit cue for hydration, especially in the first weeks of each new dose.
Most diarrhoea on Wegovy does not require a trip to A&E. But certain patterns do need prompt attention, and it is worth knowing them clearly before you need them.
Contact a pharmacist or your GP if diarrhoea is persistent (lasting more than a few days without improvement) or if you are showing signs of dehydration: a dry mouth, dark urine, dizziness or feeling faint. Children and older adults dehydrate faster, but anyone on Wegovy losing significant fluids should seek advice.
Call 999 or go to A&E if you develop severe, persistent abdominal pain that radiates towards your back, with or without vomiting. This can be a sign of acute pancreatitis. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting pancreatitis as a known but infrequent serious risk with GLP-1 medicines, including semaglutide, you can read it via the MHRA Drug Safety Update index. Diarrhoea alone is not pancreatitis, but when it accompanies that kind of abdominal pain, it should not be waited out at home.
Signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, a widespread rash) also require emergency care immediately.
If something feels off but doesn't match the above, contact our support team or speak to your prescriber. Side effects and how to manage them are part of what aftercare is for.
There is no single fix, but there are things that reliably help. Staying well hydrated is the most consistent recommendation, plain water, oral rehydration salts if needed. Eating smaller portions and avoiding very fatty, spicy or heavily processed foods during a period of GI sensitivity is worth trying before concluding that the medicine isn't tolerable.
Do not adjust your Wegovy dose yourself. If you are experiencing diarrhoea after a Wegovy injection and are questioning whether to continue, that is a conversation for your prescriber. Dose timing, whether a slower titration is possible, and whether a short pause is clinically appropriate are all things a prescriber can assess, the right call depends on your whole picture, not just the GI symptom in isolation.
For context on how semaglutide's GI side effects compare with those of tirzepatide, the semaglutide-specific diarrhoea page covers this in more detail, and our broader Wegovy overview explains how the medicine works and what the evidence shows. If you haven't started treatment yet, our prescribers discuss side effects and suitability as part of every consultation, you can check your eligibility and start your free consultation there.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.